Treatment of adrenoleukodystrophy with bone marrow transplantation

被引:22
作者
Malm, G
Ringden, O
Anvret, M
vonDobeln, U
Hagenfeldt, L
Isberg, B
Knuutila, S
Nennesmo, I
Winiarski, J
Marcus, C
机构
[1] HUDDINGE UNIV HOSP,DEPT CLIN IMMUNOL & TRANSPLANTAT SURG,S-14186 HUDDINGE,SWEDEN
[2] HUDDINGE UNIV HOSP,DEPT CLIN CHEM,S-14186 HUDDINGE,SWEDEN
[3] HUDDINGE UNIV HOSP,DEPT RADIOL,S-14186 HUDDINGE,SWEDEN
[4] HUDDINGE UNIV HOSP,DEPT PATHOL,S-14186 HUDDINGE,SWEDEN
[5] KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN
[6] KAROLINSKA HOSP,DEPT CLIN NEUROSCI,S-10401 STOCKHOLM,SWEDEN
[7] HAARTMAN INST,INST MED GENET,HELSINKI,FINLAND
关键词
D O I
10.1111/j.1651-2227.1997.tb08918.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Three children with adrenoleukodystrophy (ALD) underwent allogeneic bone marrow transplantation (BMT) between 1992 and 1993. The first boy had attention deficits, marked neuropsychological deficits and widespread demyelination in the frontal lobes on MRI before transplantation. Four years later he has mentally deteriorated and the demyelination on MRI has progressed The second boy had no symptoms but had white matter lesions on MRI when diagnosed. He was regularly followed with MRI and neuropsychological investigations until BMT 18 months later. A progress of the lesions was noted on the initial MRI investigations, and 4 months before BMT a worsening of deficits in attention and kinaesthetic praxis could be observed. He rapidly deteriorated after the transplantation and died 18 months later. Both PCR and in situ hybridization confirmed the presence of donor cells in the brain. The third boy had no symptoms but white matter lesions on MRI when diagnosed. The neuropsychological tests remained normal but a slight progress was observed on MRI just before transplantation. This boy is still healthy 3.5 years after BMT. BMT as treatment for ALD has to be considered very early, even in a child without symptoms but signs of demyelination on MRI, if a suitable donor is available.
引用
收藏
页码:484 / 492
页数:9
相关论文
共 30 条
[1]  
AHLINAKERMAN B, 1980, GRIFFITHSUTVECKLINGS
[2]   REVERSAL OF EARLY NEUROLOGIC AND NEURORADIOLOGICAL MANIFESTATIONS OF X-LINKED ADRENOLEUKODYSTROPHY BY BONE-MARROW TRANSPLANTATION [J].
AUBOURG, P ;
BLANCHE, S ;
JAMBAQUE, I ;
ROCCHICCIOLI, F ;
KALIFA, G ;
NAUDSAUDREAU, C ;
ROLLAND, MO ;
DEBRE, M ;
CHAUSSAIN, JL ;
GRISCELLI, C ;
FISCHER, A ;
BOUGNERES, PF .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (26) :1860-1866
[3]  
AUBOURG P, 1985, J LIPID RES, V26, P263
[4]  
BROWN FR, 1982, JOHNS HOPKINS MED J, V151, P164
[5]   HIGH-DOSE IMMUNOGLOBULIN IV TREATMENT IN ADRENOLEUKODYSTROPHY [J].
CAPPA, M ;
BERTINI, E ;
DELBALZO, P ;
CAMBIASO, P ;
DIBIASE, A ;
SALVATI, S .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 :69-70
[6]   ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LYSOSOMAL STORAGE DISEASES [J].
HOOGERBRUGGE, PM ;
BROUWER, OF ;
BORDIGONI, P ;
RINGDEN, O ;
KAPAUN, P ;
ORTEGA, JJ ;
OMEARA, A ;
CORNU, G ;
SOUILLET, G ;
FRAPPAZ, D ;
BLANCHE, S ;
FISCHER, A .
LANCET, 1995, 345 (8962) :1398-1402
[7]  
KNUUTILA S, CURRENT PROTOCOLS HU, P7
[8]  
KORKMAN M, 1988, THESIS HELSINKI
[9]   THE FUTURE FOR TREATMENT BY BONE-MARROW TRANSPLANTATION FOR ADRENOLEUKODYSTROPHY, METACHROMATIC LEUKODYSTROPHY, GLOBOID-CELL LEUKODYSTROPHY AND HURLER-SYNDROME [J].
KRIVIT, W ;
LOCKMAN, LA ;
WATKINS, PA ;
HIRSCH, J ;
SHAPIRO, EG .
JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 (04) :398-412
[10]  
KRIVIT W, 1995, CORRECTION GENETIC D, V3, P48